Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
Jul 12, 2023
Mushrooms are having a moment! Watch this session to learn about current and future business opportunities in the growing world of adaptogenic and functional mushrooms.
By Catie Wightman
Feb 13, 2023
In recent years, several CBD companies faced product liability lawsuits brought by consumers. Many of these cases were dismissed without prejudice or stayed until the FDA takes action to regulate CBD products. Now that the FDA said it will not take action to regulate CBD, could these cases be revived?
By Catie Wightman
Feb 9, 2023
With recent announcements from the FDA pushing CBD and hemp-derived products further into a legal gray area, can veterinarians recommend or sell these products for pets?
By Catie Wightman
Jan 17, 2023
The SB 22-205 Intoxicating Hemp Task Force's final report makes legislative and rule recommendations concerning the regulation of intoxicating and synthetic hemp products in Colorado. We compiled 10 key takeaways for hemp industry stakeholders.
By Catie Wightman
Jan 3, 2023
In this two-part VS Insights series, we discuss the potential legal implications for veterinarians to consider regarding cannabis and hemp products. This first article focuses on cannabis products, while part two focuses on hemp and hemp-derived products.
Dec 15, 2022
Watch as Vicente Sederberg LLP and EARTH Law LLC discuss the regulatory approaches for intoxicating hemp in Colorado, Oregon and California, and our projections for the future
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
By Michelle Bodian, Catie Wightman
Nov 1, 2022
Planning to ship hemp or hemp-derived CBD products? Read this first.
By Shawn Hauser, Catie Wightman, Ariane Beckman
Sep 20, 2022
Like the US, regulators in the UK are struggling to find ways to best regulate CBD and other hemp-derived products—frustrating hemp businesses across the globe. Read this VS Insights article to learn how the UK is currently regulating CBD and key findings and recommendations from the ACMD's Consumer CBD Products Report.
By Catie Wightman, Ariane Beckman
Aug 11, 2022
The FDA is cracking down on companies making unlawful drug or disease claims about their products relating to CBD by recently issuing several warning letters to address these compliance violations.
By Catie Wightman, Shawn Hauser
Jun 16, 2022
We recently hosted a webinar exploring intoxicating hemp-derived products. Read this for key takeaways from the session.
Jun 1, 2022
In VS's inaugural Impact Report, we reflect on our work over the past year, celebrate our commitment to community, and look forward to a future of positive, meaningful, and measurable impact.
By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
Apr 21, 2022
Sen. Schumer and Antonio Valdez of the National Hispanic Cannabis Council co-authored a guest column for Univision about how Latinos can benefit from the cannabis economy.
Apr 15, 2022
Kim Napoli was recognized by her peers during the 2022 NECANN Conference Community Awards
Apr 1, 2022
Watch this session exploring trending topics in hemp. During the session, members of our hemp team dive into the legality, regulation, and lawsuits surrounding minor cannabinoids, current federal hemp legislation, and what we expect and hope to see in the 2023 Farm Bill.
Dec 27, 2021
Watch this session to learn accounting best practices for cannabis businesses and how to prepare for year-end. With a focus on social equity operators, this session will advise on risk and opportunity related to the financial side of cannabis operations, as well as how to navigate the complexities of 280E.
By Michelle Bodian, Catie Wightman
Dec 17, 2021
After several extensions, the 2014 Farm Bill is finally set to expire on Dec. 31. What's next for state hemp programs and what are the 2018 Farm Bill's notable requirements?
Oct 19, 2021
Watch this recorded session for an update on recent changes in the Colorado market from members of our Colorado regulatory, corporate, and hemp teams and special guest Christopher Stefan of Cannabis Capital Advisors.
Sep 20, 2021
Kim Napoli was nominated by her peers for two awards at this years' NECANN Conference Community Awards and ultimately voted the Champion of Corporate Responsibility!
Sep 16, 2021
Find Kim Napoli on the Education Village Stage at 3 p.m. Joining Kim are Blake Mensing, Robert Jeffrey, Dick Evans and Jason Ortiz.
Aug 26, 2021
Watch this session for a dive into key elements of the regulations and an engaging discussion with special guests from the NJ CannaBusiness Association, the NJ League of Municipalities, and the US Cannabis Council.
Jul 22, 2021
VS's Jason Adelstone, Catie Wightman and Genevieve Meehan will participate in a free expungement clinic to be held on July 31, 2021 in Denver.
By Catie Wightman, Jace Pohlman
Jul 13, 2021
Move over CBD; there are new cannabinoids in town. CBD has been the most sought-after and utilized hemp-derived cannabinoid in consumer products, but due in part to technological advances, various other hemp-derived cannabinoids, like CBG, CBN, and CBC, are now creating a well-deserved buzz.
Jul 6, 2021
Marc Ross spoke with Heather Allman of Cannabis Law Report about what ESG is and why it's important for the cannabis industry.
By Caitlin Wightman, Michelle Bodian, Jace Pohlman
Jun 15, 2021
Over the first half of 2021, many states passed laws, implemented, or proposed new regulations regarding hemp cultivation, processing, and CBD products. These changes range from updates to testing, labeling, and packaging requirements, to adjustments in license requirements and limits on the types of hemp-derived products that can be sold.
Jun 15, 2021
Watch this recorded session to meet the new VS Impact & ESG team, learn more about this emerging business priority, and how to start planning and measuring your ESG practice – including Corporate Social Responsibility programs, meaningful Diversity, Equity & Inclusion efforts, environmental sustainability, and community and employee engagement.
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
By Caitlin Wightman, Michelle Bodian
Dec 23, 2020
On December 17, 2020, the Federal Trade Commission announced robust enforcement actions against companies making deceptive claims about CBD and CBG products.
Nov 25, 2020
Update on hemp legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Catie Wightman
Nov 16, 2020
If you are selling CBD products—even products sold exclusively online—you must follow retailer requirements in the states where you sell products (i.e., where your customers are located).
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020
Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.